Speaker illustration

undefined undefined undefined

Impact of statin and ezetimibe for the prevention of stroke in patients with atrial fibrillation

Event: ESC Congress 2025

Topic: Prevention

Session: Antiarrhythmic and upstream pharmacological therapy in atrial fibrillation

Thumbnail

Prediction and classification of aortic stenosis severity based on electrocardiogram with deep learning model

Event: EHRA 2025

Topic: Artificial Intelligence

Session: Artificial intelligence and arrhythmias (1)

Thumbnail

Enhancing atrial fibrillation detection during normal sinus rhythm using self-supervised electrocardiogram foundation model

Event: EHRA 2025

Topic: Artificial Intelligence

Session: Artificial intelligence and arrhythmias (1)

Thumbnail

Mobile single-lead ECG atrial fibrillation prediction enhancement integrated by standard ECG algorithm with Deep learning model

Event: ESC Congress 2024

Topic: Electrocardiogram (ECG) and Arrhythmia Analysis

Session: Innovations in cardiac health prediction: integrating deep learning with multimodal data analysis

Thumbnail

Wearable self-powered ballistic signal detectors with ferroelectric composites arrays for cardiovascular and diabetic complication

Event: EHRA 2024

Topic: Vascular Diseases

Session: Basic science 1

Thumbnail

Prediction of Atrial Fibrillation with Single-Lead Mobile ECG during Normal Sinus Rhythm using Deep Learning

Event: EHRA 2024

Topic: Artificial Intelligence

Session: eCardiology

Thumbnail

Explainable Paroxysmal Atrial Fibrillation Diagnosis Using Electrocardiogram with Artificial Intelligence

Event: EHRA 2023

Topic: Artificial Intelligence

Session: Atrial Fibrillation - Round 6 - Clinical 2

Thumbnail

Optimal anticoagulation intensity with warfarin for the prevention of thromboembolism with minimal bleeding in Asian patients with atrial fibrillation: multi-center, randomized controlled trial

Event: EHRA 2023

Topic: Oral Anticoagulation

Session: ePoster session 16

Thumbnail

Comparison of non-vitamin K antagonist oral anticoagulants and warfarin on clinical outcomes in atrial fibrillation patients presenting myocardial infarction with percutaneous coronary intervention

Event: ESC Congress 2018

Topic: Anticoagulants

Session: Are NOACs really better than VKA in the real world?

Thumbnail

Primary prevention with ICD is beneficial in 40-day survivors after acute myocardial infarction with ejection fraction less than 40%, not 35%

Event: EHRA 2018

Topic: Ventricular Arrhythmias and SCD - Prevention

Session: Ventricular arrhythmias and sudden cardiac death (clinical aspects)

Thumbnail

ESC 365 is supported by